UBIQ events

✨ 🙏 A heartfelt thank you to everyone who attended, our brilliant speakers, and dedicated chairs Leslie Anne Fendt and Pete Brockmeier for making the 4th Digital Health Conference organized by UBIQ events in Lisbon truly memorable! 🧡 Your passion, expertise, and enthusiasm brought each session to life and are inspiring new possibilities in digital health. We are so grateful to each of you for contributing to these rich discussions and transformative insights! Today’s afternoon sessions were packed with transformative ideas and practical takeaways: 🔹 AI Isn’t a “Silver Bullet” – But It’s Still a Game Changer Presented by Yulia Koinak 🔜 Websummit, Founder of VITA325. - Yulia shared a balanced perspective on AI, reminding us that gradual, strategic digitalization can drive big results in healthcare. Her insights demonstrated how AI-powered solutions that prioritize patients and streamline workflows can indeed be a game-changer. 🔹 Digital Health in an LLM World – What Matters for the Mainstream Market Presented by Peter Ohnemus, President & CEO of dacadoo - Peter highlighted the role of AI and government support in advancing digital health for chronic disease management and obesity, envisioning a future where digital health becomes mainstream and transformative. 🔹 Data-Enabled Product Development: The Future of Digital Health Solutions Presented by Ayaka Yanagisawa, Former Head of Data Analytics at Biogen - Ayaka discussed the journey of creating digital health solutions for rare diseases, stressing the importance of data, thoughtful design, and a patient-first approach. 🔹 Innovation in Clinical Drug Development – Digital Measures Integration as a Coordination Challenge - Presented by Julia Chernova, PhD, Cytel Julia delved into the integration of digital measures in clinical trials, discussing the coordination challenges and strategies to enhance patient focus and accelerate drug development. 🔹 Implementation of the AI Act & Global Perspective of AI Regulation Presented by Miguel Amador, Partner and Chief Innovation Officer at Complear Miguel provided a deep dive into the implications of the AI Act for healthcare, offering valuable guidance on navigating AI regulations in an evolving global landscape. Thank you once again to everyone for making the event a success! Together, we’re building a brighter future for digital health. Stay tuned as we continue to drive healthcare transformation. 🥇Sponsor - Tonic App 🥉Sponsors - SpotMe, Wegrow, VITA325, dacadoo #DigitalHealth #HealthcareInnovation #dhubiq #Lisbon

After two inspiring days at the 4th Digital Health Conference in Lisbon, we’re reaching the final moments.✨ Reflecting on today’s highlights, Julia Chernova, keynote on Innovation in Clinical Drug Development - Digital Measures Integration as a Coordination Challenge truly set the tone. She delved into the potential of digital biomarkers (DBMs) to make clinical trials more efficient and patient-centered, but she didn’t shy away from addressing the hurdles. Dr. Chernova emphasized that progress has been slower than anticipated, largely due to internal and external coordination challenges. She called for a more cohesive approach across departments and with external vendors to overcome these obstacles and accelerate clinical innovation. In a pivotal workshop session, Miguel Amador, Chief Innovation Officer at Complear, took a deep dive into the AI Act and its implications for healthcare. He guided us through key provisions, global regulatory comparisons, and the impact on healthcare practices, from data privacy to ethical considerations. Miguel also laid out a practical roadmap for implementing AI within healthcare, offering real-world case studies that underscored the Act’s reach. This session was essential for attendees looking to stay ahead of AI regulations and drive innovation while maintaining compliance. A heartfelt thank you to all our speakers and sponsors for their invaluable contributions to the 4th Digital Health Conference! Your expertise, engaging content, and professionalism truly elevated the event. Your punctuality and commitment to sharing insights set the tone, and the knowledge you brought fostered a vibrant networking environment that allowed attendees to connect and collaborate: The Best Digital Health Conference Lineup Ever: 🎤Ricardo Sáinz Fuertes 🎤Ghaith Sankari 🎤Lu Zheng, 🎤Leslie Anne Fendt 🎤Dan Ma 🎤Ayaka Yanagisawa 🎤Paula Salme Sandrak 🎤Miguel Amador 🎤Charlotte S. 🎤Atif Elahi 🎤Julia Chernova, 🎤Pete Brockmeier 🎤Mohamed-Ramzi TEMANNI, 🎤Dr. Friderike Bruchmann 🎤Katherine Ossenkopp 🎤Marcos Oliveira 🎤Farnaz Behroozi, 🎤Dr Bonnie Cheuk 🎤Yulia Koinak 🎤Charles Vivien 🎤Peter Ohnemus 🥇Sponsor - Tonic App 🥉Sponsors - SpotMe, Wegrow, VITA325, dacadoo And that’s a wrap! We hope everyone had an amazing time and look forward to seeing you again next year. Check out the amazing events we have in Barcelona for 2025: 7-8 April - Pharma Meets AI https://lnkd.in/dcGwGtUC 29-30 April - 4th Pharmacovigilance & Drug Safety Conference - https://lnkd.in/d8u4FxCi 12-13 May - 3rd Pharma Omnichannel HCP Engagement - https://lnkd.in/dZHV6GaD Have a great weekend!🍷

☕The audience is back from the coffee break, energized and ready for more insights. Yulia Koinak from VITA325 opened with a practical view on AI in healthcare, emphasizing that while AI can cut costs, speed up drug development, and enhance patient recruitment, it’s no “silver bullet.” She recommended a gradual approach, introducing Small Steps Before Big Changes to help organizations ease into AI integration: 📊 Data Harmonization 🤖 Internal Chatbots 💬 External Chatbots 📂 AI for Document Management ✅ Compliance Automation 📜 SOP Automation 🔬 AI in R&D Following Yuliya, Peter Ohnemus, CEO of dacadoo, presented the potential of digital health platforms to proactively manage lifestyle diseases through engagement and prevention. Peter introduced dacadoo’s Digital Health Engagement Platform (DHEP), which offers real-time health scoring to help individuals manage their health while also reducing costs for healthcare systems. By using personalized health content and interactive features, DHEP encourages positive lifestyle changes, addressing high-cost issues like obesity and diabetes while empowering patients to make informed decisions about their health. Wrapping up the session, Ayaka Yanagisawa highlighted her expertise in data-driven digital health solutions, focusing on their impact for rare diseases. She emphasized the value of data at every stage of product development, from R&D to patient care, to create compliant, scalable solutions that support a collaborative environment among patients, researchers, and healthcare providers. Ayaka stressed the need for cross-functional teams to drive meaningful progress and create tools that enhance patient outcomes while advancing medical research. With these insights, the audience has gained a richer understanding of the powerful potential of digital health. Let’s take a moment to recharge over lunch before diving into more innovative ideas this afternoon. #digitalhealth #ubiqevents #healthcareinnovation #DHUBIQ #dacadoo #vita325

🌅 Day 2 is off to an inspiring start! Today’s first two sessions are all about partnerships and innovation at the cutting edge of digital health. Kicking off the morning, Lu Zheng, Head of Value-Based Partnerships and Digital Health at Takeda and Co-Founder of Etheros HealthData Foundation, shared how partnerships are reshaping healthcare. She highlighted projects like an ADHD awareness game using storytelling to improve understanding of adult ADHD and the "Takeda For You With You" (FYWY) app, which supports patients with gastrointestinal and neurological diseases through features like public toilet locators and quality-of-life trackers. Lu also discussed digital cognitive behavioral therapy (CBT) for ADHD and the Etheros HealthData Foundation’s mission to empower individuals to own and share their health data. In another inspiring keynote, Leslie Anne Fendt, Global Digital Health Program Lead at Roche, discussed the transformative role of digital health solutions in modernizing pharmaceutical care. Her presentation focused on integrated Software-as-Medical-Device (SaMD) solutions like Roche's myVisionTrack (mVT), designed to make healthcare systems more responsive and patient-centered. A highlight of the session was Roche’s myVisionTrack, a remote vision-monitoring tool for retinal diseases like AMD. This SaMD solution empowers patients to self-assess their vision frequently and alerts healthcare providers when intervention is needed. Successfully launched in the US and UK, mVT bridges gaps between clinic visits, supporting proactive, patient-centered care with proven benefits. We are privileged to have Pete Brockmeier as our second-day moderator, bringing expertise and an engaging presence to ensure each session flows seamlessly. Our sincere thanks to our sponsors who helped us to make such a successful event: Gold Sponsor: Tonic App Bronze Sponsors: VITA325, Wegrow, dacadoo, and SpotMe Stay tuned for more updates! #DigitalHealth #HealthcareInnovation #PharmaInnovation #UBIQevents

💡Insight after insight! The 4th Digital Health Conference keeps building momentum as we uncover new paths in healthcare innovation this afternoon. We began with Charles Vivien, VP of Global Sales at Wegrow, who discussed Scaling Best Practices in Digital Health. Charles shared how AI is scaling proven healthcare strategies, where leaders optimize operations and meet the demand for personalized, data-driven solutions. Next, Dr Bonnie Cheuk, Capability Development Leader at AstraZeneca, shared her work on the Generative AI Upskilling at Scale Program. This initiative has empowered over 8,000 employees to think strategically about AI and ethics, gain hands-on experience, and collaborate on new solutions. Dr. Ricardo Sáinz Fuertes, Eisai EMEA’s Global Director of Digital Health Solutions, introduced the NEURii Project, an innovative digital therapeutics initiative supporting dementia patients. He highlighted how a patient-centred approach and collaboration can transform care for patients and caregivers alike. Pete Brockmeier, Global Associate Director of Digital Health at Novo Nordisk, shared insights on “drug + digital” solutions, offering strategies to overcome adoption hurdles and showing how companion DTx apps can simplify medication use and improve outcomes. Following Pete, Charlotte S., Senior Digital Health Scientist at Lundbeck presented Lessons Learned from Implementing Digital Health Technologies into Clinical Trials. She provided insights into integrating DHTs, like wearables, into trials, covering usability, patient involvement, and the FDA’s Remote Data Acquisition Guide. Key points emphasized patient, site, and sponsor roles in successful DHT implementation. An afternoon highlight was the Panel Discussion: Synergies in Action: Real-World Wins & Lessons in Digital Health Partnerships, moderated by Dan Ma. Panelists Dr. Friderike Bruchmann from XO Life, Katherine Ossenkopp from Future4Care, Farnaz Behroozi, from Huma, and Lu Zheng, from Takeda shared real-world examples of partnerships driving innovation, tackling challenges, and enhancing patient care. We'll conclude this inspiring day with group discussions on trending topics in digital health, followed by a networking cocktail. 🍸🍷 What a day! 🌟 https://lnkd.in/d8GG8RkM #digitalhealth #digitalinnovation #PharmaAI #digitaltherapeutics #UBIQevents

🎉The 4th Digital Health Conference has officially kicked off, and it’s a full house here at the Altis Grand Hotel in the heart of Lisbon! The morning kicked off with vibrant enthusiasm as Vladimíra Roriz, Global Project Manager at UBIQ events, opened the conference, setting the tone for a day packed with expert insights and a united drive to redefine the future of healthcare through digital innovation. Following Vladka’s welcome, we dove into the first session with Ghaith Sankari, Head of Global Digital Health Data Science at Bayer, and Paula Salme Sandrak, Product Strategist (dHealth & Health AI) at Bayer, who introduced us to the groundbreaking concept of digital twins. They explored how these virtual replicas streamline validation, cut development costs, and accelerate the launch of health AI solutions. Next, we heard from Marcos Oliveira, Senior Business Developer at Tonic App, in his compelling session, "10,000 Prompts, 367 Oncologists: Key Trends in Cancer". Marcos took us on a journey through oncologists' adoption of generative AI, revealing unique trends, usage patterns, and questions that are shaping oncology today. His data-driven insights provided a fresh perspective on how AI tools can meet the real-world needs of cancer care providers. Wrapping up the early morning keynote series before the coffee break was Dan Ma, Head of Innovation & New Commercial Partnerships and Head of the Sandoz Innovation Lab in Germany at Sandoz. Dan Ma shed light on the million-euro question: "How to Implement Digital Health Partnerships Between Corporate and Start-ups?" sharing her expertise on building productive partnerships that benefit both corporates and startups. After the break, we moved on to Atif Elahi, Digital Health Business Leader at Roche, in his engaging keynote, "You Are Not Alone: The Challenges to Deliver Digital Health Solutions from Idea to Implementation". Atif’s insights addressed the real challenges that many in the industry face, providing actionable strategies to bring digital health solutions to market. The morning concluded with a roundtable discussion moderated by Mohamed-Ramzi TEMANNI, Senior Director and Head of AI for Systems Biology, Data Science and Digital Health at Johnson & Johnson Innovative Medicine. This session fostered a collaborative dialogue on building a vibrant ecosystem for healthcare innovation, exploring the role of technology, talent, and public-private partnerships in advancing digital healthcare. A special thank you to Leslie Anne Fendt, Global Digital Health Program Lead at Roche, for her punctuality and warm presence as our moderator on this first day. Leslie’s guidance brought a welcoming and organized flow to the sessions. Thank you to our sponsors for their commitment to the success of this conference: Gold Sponsor: Tonic App Bronze Sponsors: VITA325, Wegrow, dacadoo, SpotMe Stay tuned! #digitalhealth #digitalhealthcare #digitaltwins #digitaltherapeutics #ubiqevents #dhubiq

✨Event of the Year 2025✨Pharma Meets AI Conference in Barcelona 🚀 Get ready for the Pharma Meets AI Conference in Barcelona on April 7-8, 2025 — an unmissable event for leaders, innovators, and change-makers in the pharmaceutical and AI industries! This is where the future of healthcare and technology intersect, bringing together director-level executives from global giants like Novartis, Roche, Pfizer, AstraZeneca, Bayer, Johnson & Johnson, and GSK to explore how AI is reshaping pharma as we know it. Highlights include speakers and topics: 💡Marco Andre, Global Head of Marketing & AI Excellence, Novartis - The 7 Cardinal Sins of AI: A Playful, yet Serious Take on AI's Pros and Cons - and How it Presents an Incredible Opportunity for Healthcare 💡Antonio Velasco, Chief Information Officer (CIO) Spain, AstraZeneca -AI in Healthcare: Revolution or Evolution? Opportunities and Challenges Ahead 💡David Drodge, Group Lead Digital Transformation & BPO, Roche - AI, You, and The Future of Work 💡Jorge Pou, Innovation & Commercial Operations Director, GSK 💡Vladimir Nimec, Director Data & AI, Daiichi Sankyo Europe GmbH- Customer engagement with Analytics and AI (Case Study) 💡Marta Siemaszko, Global Operations Director, Data Privacy- Digital and AI, Novartis - Regulatory and Ethical Considerations.  💡Ronan Kelly, Global Director Product Management AI & Smart Factory, Pfizer 💡Michael Schorpp🇪🇺, Head of Digital Innovation & AI, Global Regulatory Affairs, Boehringer Ingelheim 💡Christos Varsakelis, Associate Director Artificial Intelligence/Machine Learning, Johnson & Johnson Johnson 💡Zehra Erenkuş, Lead, Global Commercial Data Science, Bayer-AI Applications and Possible Use Cases at Pharma Commercial/Marketing 💡Sebastian Sbirna, Data Governance Lead – Global Data & AI (GDAI), Novo Nordisk - Establishing Operational Data Governance for AI & Analytics Self-service in the Commercial Space of Large-scale Pharma Environment From the ethical implications of AI to real-world success stories, this conference offers unmatched insights, networking, and learning opportunities for anyone invested in the digital future of healthcare. 🎫 Don’t miss your chance to be part of the future! Secure your spot today at www.pharmameetsai.com, and prepare to be inspired by the industry’s top minds. Are you interested in sponsoring or speaking at the event? Get in touch with Patrícia Giebel, Vladimíra Roriz or André Prado! #PharmaMeetsAI #AIinPharma #UBIQevents #BarcelonaConference #DigitalTransformation #PharmaAI

❓Want to Uncover the Real-World Trends Driving Cancer Care❓ Brace yourselves for an enlightening experience with Marcos Oliveira, Senior Business Developer at Tonic App, who will be delivering a keynote at the upcoming 4th Digital Health Conference in Lisbon, November 7-8. Keynote Spotlight: "A Deep Dive into 10,000 Questions Made by 367 Oncologists to a Machine Reveals the Real-World Trends in Cancer Care" Join us as Marcos explores: 🌐 GenAI adoption by oncologists compared to other specialties and across countries 👩⚕️ The Persona of Oncologists Utilizing AI 💡 Practical Applications: How Oncologists are Integrating AI into their Practice 📖 Top Scientific Content Most Consumed by Oncologists 🔬 Insights into Oncologists' Questions on Major Trends in Oncology, Including Novel Products 📊 A Data-Driven, Unbiased Perspective on AI Adoption by HCPs and Oncology’s Hottest Topics Don't miss this opportunity to gain invaluable insights into how AI is shaping the future of cancer care from real-world data! The 4th Digital Health Conference Lineup: 🎤Marcos Oliveira, Senior Business Developer - Tonic App 🎤Ricardo Sáinz Fuertes, Global Director Digital Health Solutions, NEURii Program Director - Eisai EMEA 🎤Ghaith Sankari, Head of Global Digital Health Data Science - Bayer 🎤Lu Zheng, Head of Value-Based Partnerships & Digital Health, Europe & Canada - Takeda 🎤Leslie Anne Fendt, Integrated Solutions Program Lead - Roche 🎤Dan Ma, Head of Innovation & New Commercial Partnerships - Sandoz 🎤Ayaka Yanagisawa, Former Head of Data Analytics, Digital Health Solutions - Biogen 🎤Paula Salme Sandrak, Product Strategist (dHealth & Health AI) - Bayer 🎤Miguel Amador, Partner & Chief Innovation Officer - Complear 🎤Charlotte S., Senior Digital Health Scientist - Lundbeck 🎤Atif Elahi, Digital Health Business Leader - Roche 🎤Julia Chernova, Director, Biostatistics - Cytel 🎤Pete Brockmeier, Global Associate Director, Digital Health - Novo Nordisk 🎤Mohamed-Ramzi TEMANNI, Senior Director, Johnson & Johnson Innovative Medicine 🎤Dr. Friderike Bruchmann, Co-Founder & CEO - XO Life 🎤Katherine Ossenkopp, Country Manager Germany - Future4Care 🎤Farnaz Behroozi, Behroozi, Head of Pharma - Huma 🎤Dr Bonnie Cheuk, Global Capability Development Leader - Digital, Data, AI and Learning Agility, AstraZeneca 🎤Yulia Koinak, Founder - VITA325 🎤Charles Vivien, Vice President of Global Sales - Wegrow 🎤Peter Ohnemus, President & CEO - dacadoo 🥇Sponsor - Tonic App 🥉Sponsors - SpotMe, Wegrow, VITA325, dacadoo Last seats available at https://lnkd.in/d8GG8RkM #dhubiq #digitalhealth #tonicapp #cancercare

🎆 The 4th Digital Health Conference #dhubiq is kicking off this Thursday, November 7th at the Altis Grand Hotel in Lisbon! 🌍✨ This year, we’re honored to have two incredible chairpersons leading the charge: 📅 Day 1 - Leslie Anne Fendt, Global digital health program lead, myVisionTrack, at Roche 📅 Day 2 - Pete Brockmeier, Global Associate Director, Digital Health at Novo Nordisk Looking forward to the amazing LineUp: 🎤Ricardo Sáinz Fuertes, Global Director Digital Health Solutions, NEURii Program Director - Eisai EMEA 🎤Atif Elahi, Digital Health Business Leader - Roche 🎤Ghaith Sankari, Head of Global Digital Health Data Science - Bayer 🎤Paula Salme Sandrak, Product Strategist (dHealth & Health AI) - Bayer 🎤Lu Zheng, Head of Value-Based Partnerships & Digital Health, Europe & Canada - Takeda 🎤Leslie Anne Fendt, Integrated Solutions Program Lead - Roche 🎤Dan Ma, Head of Innovation & New Commercial Partnerships - Sandoz 🎤Ayaka Yanagisawa, Former Head of Data Analytics, Digital Health Solutions - Biogen 🎤Marcos Oliveira, Senior Business Developer - Tonic App 🎤Miguel Amador, Partner & Chief Innovation Officer - Complear 🎤Charlotte S., Senior Digital Health Scientist - Lundbeck 🎤Julia Chernova, Director, Biostatistics - Cytel 🎤Pete Brockmeier, Global Associate Director, Digital Health - Novo Nordisk 🎤Mohamed-Ramzi TEMANNI, Senior Director, Johnson & Johnson Innovative Medicine 🎤Dr. Friderike Bruchmann Bruchmann, Co-Founder & CEO - XO Life 🎤Katherine Ossenkopp, Country Manager Germany - Future4Care 🎤Farnaz Behroozi, Head of Pharma - Huma 🎤Dr Bonnie Cheuk, Global Capability Development Leader - Digital, Data, AI and Learning Agility, AstraZeneca 🎤Yulia Koinak, Founder - VITA325 🎤Charles Vivien, Vice President of Global Sales - Wegrow 🎤Peter Ohnemus, President & CEO - dacadoo 🥇Sponsor - Tonic App 🥉Sponsors - SpotMe, Wegrow, VITA325, dacadoo Last seats available at https://lnkd.in/d8GG8RkM #dhubiq #digitalhealth #lisbon #conference

❓How Will Digital Health Evolve in an LLM-Powered World❓ Join Peter Ohnemus, President & CEO at dacadoo and a renowned global expert in digital health, as he explores how governments are driving digital health forward, with AI leading the charge. Peter will cover everything from the impact on chronic diseases and obesity to the latest on GLP-1 treatments and the documented benefits for Life & Health carriers. Having spoken at prestigious forums like the World Economic Forum, MIT, and the Royal Institute of Medicine, and featured on CNN and National TV, Peter’s insights promise a transformative view of what’s next in healthcare. 📆 Don’t miss dacadoo’s keynote on November 8th at 11:45h - "Digital Health Becoming Mainstream in an LLM-Based World – What Will Become Relevant for the Mainstream Digital Health Market" The 4th Digital Health Conference LineUp: 🎤Peter Ohnemus, President & CEO - dacadoo 🎤Ricardo Sáinz Fuertes, Global Director Digital Health Solutions, NEURii Program Director - Eisai EMEA 🎤Atif Elahi, Digital Health Business Leader - Roche 🎤Ghaith Sankari, Head of Global Digital Health Data Science - Bayer 🎤Paula Salme Sandrak, Product Strategist (dHealth & Health AI) - Bayer 🎤Lu Zheng, Head of Value-Based Partnerships & Digital Health, Europe & Canada - Takeda 🎤Leslie Anne Fendt, Integrated Solutions Program Lead - Roche 🎤Dan Ma, Head of Innovation & New Commercial Partnerships - Sandoz 🎤Ayaka Yanagisawa, Former Head of Data Analytics, Digital Health Solutions - Biogen 🎤Marcos Oliveira, Senior Business Developer - Tonic App 🎤Miguel Amador, Partner & Chief Innovation Officer - Complear 🎤Charlotte S., Senior Digital Health Scientist - Lundbeck 🎤Julia Chernova, Director, Biostatistics - Cytel 🎤Pete Brockmeier, Global Associate Director, Digital Health - Novo Nordisk 🎤Mohamed-Ramzi TEMANNI, Senior Director, Johnson & Johnson Innovative Medicine 🎤Dr. Friderike Bruchmann, Co-Founder & CEO - XO Life 🎤Katherine Ossenkopp, Country Manager Germany - Future4Care 🎤Farnaz Behroozi, Behroozi, Head of Pharma - Huma  🎤Dr Bonnie Cheuk, Global Capability Development Leader - Digital, Data, AI and Learning Agility, AstraZeneca 🎤Yulia Koinak, Founder - VITA325 🎤Charles Vivien, Vice President of Global Sales - Wegrow 🥇Sponsor - Tonic App 🥉Sponsors - SpotMe, Wegrow, VITA325, dacadoo Don't miss this visionary session!  https://lnkd.in/d8GG8RkM  #DigitalHealth #AIPharma #Healthcareinnovation #digitaltransformation